Steven Cohen acquired 497 Thousand Catalyst Pharmaceuticals shares worth $8.08 Million. That's 0.02% of their equity portfolio (582nd largest holding). The first Catalyst Pharmaceuticals trade was made in Q4 2014. Since then Steven Cohen bought shares seven more times and sold shares on eight occasions. The stake costed the investor $6.73 Million, netting the investor a gain of 20% so far.